Clinical Trial Detail

NCT ID NCT03022409
Title A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors AstraZeneca
Indications

head and neck squamous cell carcinoma

Therapies

Olaparib

AZD6738

Age Groups: adult senior

No variant requirements are available.